The EVO ICL is an advanced soft-material lens, composed of 100% biocompatible collagen copolymer. It provides permanent vision correction that is sharp and vivid. There is no maintenance associated with the lens, and it is intended to remain in place as long as you are satisfied with your vision. If at any point your vision changes or you wish to have them removed, this can be done easily. Because the cornea is in its natural state, you are able to pursue other vision correction options.
In short, the advantages of ICLs include:
The ICL procedure is an outpatient procedure is typically painless (and typically takes less than 20-30 minutes). Prior to the procedure, the patient receives topical anesthesia drops to minimize discomfort. Then the eye surgeon creates a very small opening to insert the lens into the eye with an injector. Once the lens is injected, it unfolds in the eye and the procedure is complete. Patients typically experience minimal discomfort and return to work the next day. You can experience improved vision right away and a quick recovery time.
The risks of implantable contact lenses are similar to those of other refractive procedures like LASIK and PRK. However, ICLs do not have the complications associated with physically changing the shape of the eye. In addition, if any complications should occur, ICLs are removable. Complications related to ICLs include infection, increased intraocular pressure, and the possibility of accidental damage to the crystalline lens during the procedure. In most cases, these complications can be corrected by the eye surgeon. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO ICL surgery, especially the potential benefits, risks, and complications.
At Clemson Eye, we always recommend that you have a vision consultation to determine your best vision correction plan. If ICLs are not a good option for you, we can consider other options.
Patients who have undergone any ophthalmic surgery or who have a history of eye diseases such as iritis, glaucoma, or diabetic retinopathy are not considered good candidates for ICLs. In addition, ICLs may not be the best course of action for patients:
Through implantable contact lenses, we can offer patients with moderate to severe myopia a high quality of vision and excellent, stable outcomes. We are proud to be the only eye surgeons in the Upstate currently offering this refractive procedure.
$200 Consultation Fee *
*The consultation fee will be applied to the overall pricing of the surgery when scheduled.
1ICL in Treatment of Myopia (ITM) Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia. Ophthalmology. 2004;111:1683-1692.